Li et al. (19) reported that DAC treatment resulted in a CD8+ T cell-mediated anti-OS reaction via increasing expression of the MAGE-A family proteins and NY-ESO-1 in OS cells, both in vitro and in vivo, which has also been reported in other tumor cells (38, 39). This evidence concerns the gene CD8A and neoplasm.